Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | MPL | P40238 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17616200 | 0.98 | GABRA1 (0.45) | GABRA1GABRB2ALOX5GABRA5GABRA3 | |
| SCHEMBL20429678 | 0.98 | GABRA1 (0.45) | GABRA1GABRB2ALOX5GABRA5GABRA3 | |
| SCHEMBL17791133 | 0.92 | GABRA1 (0.46) | GABRA1GABRB2ALOX5GABRA5GABRA3 | |
| SCHEMBL16803344 | 0.91 | MPL (0.43) | GABRA1GABRB2ALOX5MPLRARB | |
| SCHEMBL14371119 | 0.90 | GABRA1 (0.45) | GABRA1GABRB2ALOX5GABRA5GABRA3 | |
| SCHEMBL9406303 | 0.89 | RARB (0.47) | RARB | |
| SCHEMBL20346164 | 0.89 | CYP19A1 (0.38) | GABRA1GABRB2ALOX5FFAR4CNR2 | |
| SCHEMBL17614859 | 0.88 | RARB (0.46) | RARB | |
| SCHEMBL10615735 | 0.88 | RARB (0.49) | RARB | |
| SCHEMBL29873595 | 0.87 | GABRA1 (0.42) | GABRA1GABRB2ALOX5FFAR4MPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20230265345-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND APPLICATION OF LIQUID CRYSTAL COMPOSITION | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2023-08-24 | — | — | US | disclosed |
| US-20230167362-A1 | NEGATIVE LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MAT CO ITD (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167362-A1 | NEGATIVE LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MAT CO ITD (CN) | 2023-06-01 | — | — | US | disclosed |
| WO-2021253625-A1 | NEGATIVE LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| WO-2021002205-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | DIC株式会社 | 2021-01-07 | — | — | WO | disclosed |
| US-20200399539-A1 | POLYMERIZABLE COMPOUND AS WELL AS LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE EACH INCLUDING POLYMERIZABLE COMPOUND | DIC CORPORATION (JP) | 2020-12-24 | — | — | US | disclosed |
| WO-2020044833-A1 | LIQUID CRYSTAL COMPOSITION | DIC株式会社 | 2020-03-05 | — | — | WO | disclosed |
| US-20190119573-A1 | COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2019-04-25 | — | — | US | disclosed |
| US-20170226419-A1 | POLYMERIZABLE-MONOMER-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170226419-A1 | POLYMERIZABLE-MONOMER-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| EP-3159393-A1 | POLYMERIZABLE-MONOMER-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC Corporation (JP) | 2017-04-26 | — | — | EP | disclosed |
| US-9580652-B2 | Liquid crystal compound, liquid crystal composition including the same and liquid crystal display including the liquid crystal composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-28 | — | — | US | disclosed |
| US-9580652-B2 | Liquid crystal compound, liquid crystal composition including the same and liquid crystal display including the liquid crystal composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-28 | — | — | US | disclosed |
| US-20160083653-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME AND LIQUID CRYSTAL DISPLAY INCLUDING THE LIQUID CRYSTAL COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-24 | — | — | US | disclosed |
| US-20160083653-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME AND LIQUID CRYSTAL DISPLAY INCLUDING THE LIQUID CRYSTAL COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | GABRA1 4237/4885GABRB2 4315/4885ALOX5 3165/4885 |
| US-20200399539-A1 | POLYMERIZABLE COMPOUND AS WELL AS LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE EACH INCLUDING POLYMERIZABLE COMPOUND | OCIAD2, PKN2, SKP1 | GABRA1 4237/4885GABRB2 4315/4885ALOX5 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.